ROYALTY TERMINATION AGREEMENTRoyalty Termination Agreement • December 19th, 2011 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • Florida
THIS ROYALTY TERMINATION AGREEMENT (this “Agreement”) is made as of November 17, 2010, by and between BIOVEST INTERNATIONAL, INC., a Delaware corporation (“Biovest”), and ACCENTIA BIOPHARMACEUTICALS, INC., a Florida corporation (“Accentia”).
STOCK PLEDGE AGREEMENTStock Pledge Agreement • December 19th, 2011 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • California
THIS STOCK PLEDGE AGREEMENT (this “Agreement”), dated as of November 17, 2010, is made and entered into by and between ACCENTIA BIOPHARMACEUTICALS, INC., a Florida corporation (the “Pledgor”), and McKESSON CORPORATION, a Delaware corporation (the “Secured Party”), pursuant to the terms of the Accentia Plan (as defined below), based on the following additional facts and understandings:
LOAN SECURITY TERMINATION AGREEMENT (Biovest International, Inc.)Loan Security Termination Agreement • December 19th, 2011 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • New York
THIS LOAN SECURITY TERMINATION AGREEMENT (this “Agreement”) is made as of December 15, 2011, by and among LV ADMINISTRATIVE SERVICES, INC., as Administrative and Collateral Agent for the Lenders (“LV”), the LENDERS who are signatories hereto (the “Lenders”), and BIOVEST INTERNATIONAL, INC., a Delaware corporation (“Biovest”).
LOAN PREPAYMENT, MODIFICATION AND SECURITY TERMINATION AGREEMENT (Accentia Biopharmaceuticals, Inc.)Modification and Security Termination Agreement • December 19th, 2011 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • New York
THIS LOAN PREPAYMENT, MODIFICATION AND SECURITY TERMINATION AGREEMENT (this “Agreement”) is made as of December 15, 2011, by and among LV ADMINISTRATIVE SERVICES, INC., as Administrative and Collateral Agent for the Lenders (“LV”), the LENDERS who are signatories hereto (the “Lenders”), and ACCENTIA BIOPHARMACEUTICALS, INC., a Florida corporation (“Accentia”).
Private & Confidential 31st of October 2011 [*] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS AND AN ASTERISK, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2...Asset Purchase Agreement • December 19th, 2011 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Luxembourg L1724 LUXEMBOURG, registered in Registre de Commerce et des Sociétés Luxembourg under number B 147663, duly represented by Mr. André Haik in its capacity as co-gérant (the “LA-SER”),
ContractAccentia Biopharmaceuticals Inc • December 19th, 2011 • Pharmaceutical preparations • New York
Reference is made to (a) that certain Term Loan & Security Agreement dated as of November 17, 2010 (as amended, supplemented, restated or modified from time to time, the “Term Loan & Security Agreement”) by and between LV Administrative Services, Inc. (“LV”) as Agent for and on behalf of each of the creditor parties named therein (the “Lenders”) and Accentia Biopharmaceuticals, Inc. (“Accentia”); and (b) the Ancillary Agreements (as defined in the Term Loan & Security Agreement). Capitalized terms used but not defined herein shall have the meanings ascribed thereto in the Term Loan & Security Agreement or the Ancillary Agreements, as applicable.
